Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

Takeda Establishes Takeda Pharmaceuticals Mexico, S.A. de C.V. Expanding Presence in North America

Posted : Tue, 03 Nov 2009 15:03:00 GMT
Author : Takeda Pharmaceuticals North America, Inc.
Category : Press Release
News Alerts by Email ( click here )
News | Home
Company to be based in Mexico City DEERFIELD, Ill., Nov. 3

DEERFIELD, Ill., Nov. 3 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc., today announced the incorporation of Takeda Pharmaceuticals Mexico, S.A. de C.V. This expansion strengthens the company's North American presence, bolstering existing operations in the United States and Canada. Takeda Pharmaceuticals Mexico will be headquartered in Mexico City.

The Mexican pharmaceutical market is currently the 12th largest in the world and represents more than 25 percent of the Latin American market. Additionally, the prevalence of diabetes in Mexico is among the highest in the world.

"With a population of 109 million people, Mexico represents an important expansion opportunity for Takeda," said Shinji Honda, President and Chief Executive Officer, Takeda Pharmaceuticals North America, Inc. "The needs of patients in Mexico fit well with our product portfolio, so we are excited to bring important medicines to this vital region."

Takeda Mexico plans to file a new drug application with the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) in 2010. Takeda focuses on a variety of therapeutic areas, including lifestyle-related diseases, oncology and urological diseases, central nervous system diseases, and gastroenterological diseases.

"For us, it is a pleasure that Takeda has chosen Mexico to start operations," said Bruno Ferrari, Chief Executive Officer of ProMexico, Mexico's Federal Government entity responsible for bringing direct foreign investment into Mexico as well as to support the country's foreign trade. "Takeda's experience is of great importance not only because of the company's contributions to Mexico's health system, but also the jobs that will be brought to Mexico's qualified labor force."

Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc., and Takeda Global Research & Development Center, Inc., are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and gastroenterology treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for diabetes, cardiovascular disease, gastroenterology, neurology and other conditions. Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. To learn more about these Takeda companies, visit www.tpna.com.

SOURCE Takeda Pharmaceuticals North America, Inc.


Copyright © 2008 PR Newswire. All rights reserved.

Share/Save/Bookmark

Article : Takeda Establishes Takeda Pharmaceuticals Mexico, S.A. de C.V. Expanding Presence in North America
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

Power Tagging Announces National Science Foundation Grant
Company Selected Amongst Thousands to Continue to Evolve Data Structures to Support the Emerging NIST Smart Grid Standards./I/P P(PRWEB) November 22, 2009 -- Power Tagging, a leading provider of next generation smart grid communications technologies, today announced that the company has...

2011 Cadillac CTS Coupe: New Sports Coupe Is Cadillac's Most Dramatic Design
LOS ANGELES, Nov. 23 /PRNewswire/ -- Cadillac today unveiled the 2011 CTS Coupe, the latest and most dramatic of the brand's series of new designs to reach production. Slated to arrive in Cadillac showrooms in the spring of 2010, the CTS Coupe is a new luxury sports coupe designed t...

U.S. Census Bureau Daily Feature for Nov. 23
WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ -- Following is the daily "Profile America" feature from the U.S. Census Bureau: (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO)

Majorities Reject Banning Defamation of Religion: 20 Nation Poll
COLLEGE PARK, Md., Nov. 23 /PRNewswire-USNewswire/ -- As the UN General Assembly prepares to debate a proposal calling for nations to take action against the defamation of religion, majorities in 13 of 20 nations polled around the world support the right to criticize a religion.

Amid the Flu Epidemic, Don't Forget RSV in Young Children
RSV found to cause far more emergency department visits and hospitalizations than seasonal flu BOSTON, Nov. 23 /PRNewswire-USNewswire/ -- Influenza, particularly H1N1, has understandably captured the attention of public health officials, the media and the public...

Peter Wilkinson Appointed IPREX President Asia Pacific
ATLANTA - Peter Wilkinson, CEO of Wilkinson PR, a full service corporate affairs and public relations agency with offices in Sydney, Melbourne and Perth, has been appointed President Asia Pacific of IPREX, the global corporation of independent public relations and communication firms.

Report Finds Girls' Schools in Afghanistan Face Highest Risk of Violence; Suggests Steps for Preventing Attacks
- New study supports community-based approach to education in Afghanistan - ATLANTA, Nov. 23 /PRNewswire-USNewswire/ -- Today CARE, the World Bank and the Afghanistan government released "Knowledge on Fire: Attacks on Education in Afghanistan," a groun...

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.